Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis
Combined company gets $30M financing and cash runway into H2 2028; RA Phase 2 topline data are expected in H1 2028.
Read the full articleYou might also wanna read
Turn User Signal Into What You Build Next
Builder.io·just now
エージェントに渡した参照メモの7割は届いていませんでした — head で切る運用の限界を測った記録
antigravitylab.net·just now
Sustainable development: EU Commission reports €60BN in imports under GSP scheme
ieu-monitoring.com·6m ago
Base trading and AI pivot raises questions – ‘Shows weakness as Robinhood Chain takes off’
cryptonews.net·14m ago
Peter Schiff Says Strategy Is No Longer a Leveraged Bitcoin Bet, Warns MSTR Shareholders of Infinite Dilution
cryptonews.net·15m ago
Cómo generar videos con IA desde blogs en 2026
Digen AI·17m ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.